Related Experiment Video
Updated: Aug 3, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Heparin: biochemistry, therapy, and laboratory monitoring
Heparin has been used extensively in the treatment of venous thrombosis and pulmonary embolus and more recently as a prophylactic measure in high-risk patient populations. The chemistry and biologic, pharmacologic, and physiologic actions of heparin are discussed, with some emphasis on the role of antithrombin III. The various modes of heparin administration, dosage regimens, requirements, and indications for therapy are reviewed. Full-dose and minidose heparin therapy are discussed in detail. The advantages and disadvantages of the various laboratory tests used to monitor heparin therapy are covered, along with standardization of heparin preparations. Finally, complications associated with heparin therapy are pointed out.
Heparin has been used extensively in the treatment of venous thrombosis and pulmonary embolus and more recently as a prophylactic measure in high-risk patient populations. The chemistry and biologic, pharmacologic, and physiologic actions of heparin are discussed, with some emphasis on the role of antithrombin III. The various modes of heparin administration, dosage regimens, requirements, and indications for therapy are reviewed. Full-dose and minidose heparin therapy are discussed in detail. The advantages and disadvantages of the various laboratory tests used to monitor heparin therapy are covered, along with standardization of heparin preparations. Finally, complications associated with heparin therapy are pointed out.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Continuous Renal Replacement Therapy

